No Data
Cathie Wood's ARK Investment Buys 36K Shares of 10x Genomics Today
10x Genomics Secures Court Injunction Against Bruker's Sale of GeoMx Products in US
10x Genomics: Injunction Expected to Prohibit Bruker From Making, Using, Selling or Offering to Sell in U.S. GeoMx Digital Spatial Profiler and Associated Instruments, Reagents and Services for RNA and Protein Detection >BRKR
Reported Earlier, Delaware Jury Awards 10x Genomics $31.7M In Patent Case Against NanoString; Permanent Injunction On GeoMx Takes Effect January 10, 2025, With Royalties For Existing Installations; Additional Rulings On CosMx Expected Spring 2025
Trending Stocks Today | Syntec Optics Holdings Shoots up 63.48% Post-Market
Worst Performing Stocks for Tax Loss Selling – Wolfe
